{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:20:47Z","timestamp":1775881247971,"version":"3.50.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.thromres.2010.09.019","type":"journal-article","created":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T09:30:14Z","timestamp":1287653414000},"page":"505-512","source":"Crossref","is-referenced-by-count":30,"title":["Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis \u2013 A concise review"],"prefix":"10.1016","volume":"127","author":[{"given":"Shrimati","family":"Shetty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanjaksha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2010.09.019_bb0005","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1046\/j.1365-2141.2000.02349.x","article-title":"Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group","volume":"111","author":"Heller","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0010","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1053\/gast.2001.23083","article-title":"G20210A prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosis","volume":"120","author":"Madonna","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1572-0241.2006.00353.x","article-title":"Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis","volume":"101","author":"Darwish Murad","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0020","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/jhep.2001.27948","article-title":"Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India","volume":"34","author":"Mohanty","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0025","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study","volume":"96","author":"Janssen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2010.09.019_bb0030","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.3748\/wjg.14.2858","article-title":"Etiology and portal vein thrombosis in Budd-Chiari syndrome","volume":"14","author":"Uskudar","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0035","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1309\/F2U1XBV4RXYUAYG0","article-title":"Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India","volume":"121","author":"Bhattacharyya","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","article-title":"Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors","volume":"31","author":"Denninger","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.20591","article-title":"Risk factors for thrombophilia in extrahepatic portal vein obstruction","volume":"41","author":"Primignani","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00042737-200507000-00009","article-title":"Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors","volume":"17","author":"Mangia","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0055","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0002-9343(88)90299-9","article-title":"Lupus anticoagulant and portal hypertension","volume":"84","author":"Ordi","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2010.09.019_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajh.10149","article-title":"Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome","volume":"71","author":"Li","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0065","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0168-8278(02)00434-8","article-title":"European Group for the Study of Vascular Disorders of the Liver. Budd-Chiari syndrome: a review by an expert panel","volume":"38","author":"Janssen","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to APC","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2010.09.019_bb0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0038-1655963","article-title":"Prevalence of factor V Leiden mutation in non-European populations","volume":"77","author":"Pepe","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.09.019_bb0080","first-page":"435","article-title":"Factor V Leiden in patients with venous thrombosis in Slovak population","volume":"23","author":"Simkova","year":"2004","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.thromres.2010.09.019_bb0085","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJM199412083312305","article-title":"Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg\u2013>Gln mutation in the gene for factor V","volume":"331","author":"Greengard","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2010.09.019_bb0090","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/gut.40.6.798","article-title":"Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis","volume":"40","author":"Mahmoud","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2010.09.019_bb0095","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/gut.48.2.264","article-title":"Factor V Leiden related Budd-Chiari syndrome","volume":"48","author":"Deltenre","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2010.09.019_bb0100","first-page":"211","article-title":"Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study","volume":"24","author":"Kumar","year":"2005","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/gut.43.1.146b","article-title":"Prevalence of the factor V Leiden mutation in portal and hepatic vein thrombosis","volume":"43","author":"Das","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2010.09.019_bb0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0016-5085(99)70238-6","article-title":"Frequent factor II G20210A mutation in idiopathic portal vein thrombosis","volume":"116","author":"Chamouard","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep.510310213","article-title":"Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis","volume":"31","author":"Amitrano","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0125","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00277-004-0921-4","article-title":"Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study","volume":"83","author":"Salama","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ajh.10103","article-title":"Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems","volume":"70","author":"Bombeli","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/107602960100700214","article-title":"Venous thromboembolism in young patients from western India: a study","volume":"7","author":"Ghosh","year":"2001","journal-title":"Clin Appl Thromb Hemost"},{"issue":"88","key":"10.1016\/j.thromres.2010.09.019_bb0140","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"15","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2010.09.019_bb0145","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","article-title":"Geographic distribution of the 20210 G to A prothrombin variant","volume":"79","author":"Rosendaal","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.09.019_bb0150","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.STR.29.9.1765","article-title":"Prothrombin Gene G20210\u2192A Transition Is a Risk Factor for Cerebral Venous Thrombosis","volume":"29","author":"Reuner","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2010.09.019_bb0155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1160\/TH07-08-0526","article-title":"Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis","volume":"99","author":"Dentali","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.09.019_bb0160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0038-1647311","article-title":"Extra-hepatic synthesis of protein S","volume":"64","author":"Schwarz","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.09.019_bb0165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/ajcp\/78.2.236","article-title":"Budd-Chiari Syndrome and antithrombin III deficiency","volume":"78","author":"McClure","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0170","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1055\/s-0038-1660107","article-title":"A protein S deficient family with portal vein thrombosis","volume":"54","author":"Sas","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.09.019_bb0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0037-1614438","article-title":"Hyperhomocysteinemia, atherosclerosis and thrombosis","volume":"81","author":"Cattaneo","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.09.019_bb0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000097462","article-title":"Congenital prothrombotic disorders in children with peripheral venous and arterial thromboses","volume":"117","author":"Albisetti","year":"2007","journal-title":"Acta Haematol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archinte.167.5.497","article-title":"No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study","volume":"167","author":"Bezemer","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2010.09.019_bb0190","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1872-034X.2010.00628.x","article-title":"Portal vein thrombosis in Egyptian patients with liver cirrhosis: Role of methylenetetrahydrofolate reductase C677T gene mutation","volume":"40","author":"Gabr","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.thromres.2010.09.019_bb0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00042737-200503000-00013","article-title":"Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis","volume":"17","author":"Erkan","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0200","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3324\/haematol.11161","article-title":"Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children\u2013results of a multicenter studys","volume":"92","author":"Kurnik","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2010.09.019_bb0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2141.2007.06693.x","article-title":"Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients","volume":"138","author":"Shetty","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1160\/TH06-07-0407","article-title":"Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis","volume":"97","author":"de Bruijne","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.09.019_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.10192","article-title":"PAI-1 gene 4G\/5G genotype: A risk factor for thrombosis in vessels of internal organs","volume":"71","author":"Balta","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0220","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood-2009-03-211557","article-title":"European Network for Vascular Disorders of the Liver (EN-Vie). Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome","volume":"115","author":"Hoekstra","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2010.09.019_bb0225","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2141.2005.05490.x","article-title":"Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis","volume":"129","author":"Chait","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0230","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2008.07258.x","article-title":"The JAK2 V617F mutation and thrombosis","volume":"143","author":"Austin","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0235","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2141.1990.tb02647.x","article-title":"Primary polycythaemia: positive diagnosis using the differential response of primitive and mature erythroid progenitors to erythropoietin, interleukin 3 and alpha-interferon","volume":"75","author":"Dudley","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0240","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2001-12-0349","article-title":"Polycythemia vera: myths, mechanisms, and management","volume":"100","author":"Spivak","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2010.09.019_bb0245","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4065\/80.7.947","article-title":"The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis","volume":"80","author":"Tefferi","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.thromres.2010.09.019_bb0250","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2010.09.019_bb0255","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2010.09.019_bb0260","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2010.09.019_bb0265","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.thromres.2010.09.019_bb0270","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2010.09.019_bb0275","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1182\/blood-2008-02-137687","article-title":"MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction","volume":"111","author":"Bergamaschi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2010.09.019_bb0280","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2009.02.004","article-title":"Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review","volume":"124","author":"Lussana","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2010.09.019_bb0285","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1053\/j.gastro.2006.04.008","article-title":"Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome","volume":"130","author":"Patel","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0290","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1751-553X.2007.00973.x","article-title":"The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein","volume":"30","author":"Goulding","year":"2008","journal-title":"Int J Lab Hematol"},{"issue":"19","key":"10.1016\/j.thromres.2010.09.019_bb0295","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MBC.0b013e3283049662","article-title":"Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome","volume":"l","author":"Colaizzo","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2010.09.019_bb0300","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hep.21601","article-title":"High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis","volume":"45","author":"De Stefano","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0305","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/hep.21435","article-title":"Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis","volume":"44","author":"Primignani","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1538-7836.2006.02277.x","article-title":"The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis","volume":"5","author":"Colaizzo","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.09.019_bb0315","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1007\/s10620-008-0225-y","article-title":"JAK2V617F mutation in patients with portal vein thrombosis","volume":"53","author":"Bayraktar","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.thromres.2010.09.019_bb0320","first-page":"1712","article-title":"Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome","volume":"91","author":"Smalberg","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2010.09.019_bb0325","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1538-7836.2007.02384.x","article-title":"JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis","volume":"5","author":"Regina","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.09.019_bb0330","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1309\/JA1WD8JNVLGYNQYE","article-title":"JAK2 V617F mutation in patients with catastrophic intra-abdominal thromboses","volume":"127","author":"McMahon","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0335","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1182\/blood-2007-11-125328","article-title":"The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases","volume":"111","author":"Kiladjian","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2010.09.019_bb0340","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1182\/blood-2008-12-196014","article-title":"JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis","volume":"113","author":"Dentali","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2010.09.019_bb0345","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2010.09.019_bb0350","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Cancer Genome Project. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2010.09.019_bb0355","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2010.09.019_bb0360","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08880010701884733","article-title":"Antiphospholipids antibodies in a 12-month-old presenting with idiopathic thrombocytopenic purpura","volume":"25","author":"Nseir","year":"2008","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0365","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejogrb.2007.05.014","article-title":"A comprehensive screening analysis of antiphospholipid antibodies in Indian women with fetal loss","volume":"137","author":"Vora","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0370","first-page":"71","article-title":"Portal and pulmonary hypertension in a case of systematic lupus erythematosus: possible relationship with a clotting abnormality","volume":"7","author":"Mackworth-Young","year":"1984","journal-title":"Eur J Rheumatol Inflamm"},{"key":"10.1016\/j.thromres.2010.09.019_bb0375","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/096120339500400314","article-title":"Portal hypertension associated with anticardiolipin antibodies in a case of systemic lupus erythematosus","volume":"4","author":"Takahaski","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2010.09.019_bb0380","first-page":"723","article-title":"Antiphospholipid antibodies: limitations and potential use in liver diseases","volume":"20","author":"Valla","year":"1996","journal-title":"Gastroent\u00e9rol Clin Biol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0385","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0028-1085099","article-title":"Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy","volume":"28","author":"Perarnau","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.thromres.2010.09.019_bb0390","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0016-5085(86)90855-3","article-title":"Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study","volume":"90","author":"Valla","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0395","first-page":"858","article-title":"Budd-Chiari syndrome: a common complication of Beh\u00e7et's disease","volume":"92","author":"Bayraktar","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0400","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(95)12360-1","article-title":"Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology","volume":"348","author":"Soci\u00e9","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2010.09.019_bb0405","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jhep.2008.12.020","article-title":"High levels of factor VIII and risk of extra-hepatic portal vein obstruction","volume":"50","author":"Martinelli","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0410","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005792-199401000-00003","article-title":"Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature","volume":"73","author":"Dilawari","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.thromres.2010.09.019_bb0415","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.20064","article-title":"Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome","volume":"39","author":"Murad","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-8278(95)80252-5","article-title":"Epidemiological and clinical features of Budd-Chiari syndrome in Japan","volume":"22","author":"Okuda","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0425","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0140-6736(93)91712-U","article-title":"Management of hepatic venous outflow obstruction","volume":"342","author":"Kohli","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2010.09.019_bb0430","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1440-1746.1995.tb01095.x","article-title":"Membranous obstruction of inferior vena cava in Taiwan","volume":"10","author":"Lu","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0435","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00005792-198503000-00005","article-title":"Membranous obstruction of the inferior vena cava in the United States","volume":"64","author":"Rector","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.thromres.2010.09.019_bb0440","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0168-8278(89)90025-1","article-title":"Hepatic vein webs and resistant ascites. Diagnosis, management and implications","volume":"8","author":"Vickers","year":"1989","journal-title":"J Hepatol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0445","first-page":"77","article-title":"Shyamkumar NK.Changing profile of Budd Chiari syndrome in India","volume":"26","author":"Eapen","year":"2007","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0450","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/hep.1840110610","article-title":"Hepatic vein thrombosis in Beh\u00e7et's disease","volume":"11","author":"Bismuth","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2010.09.019_bb0455","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0168-8278(00)80218-4","article-title":"Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome","volume":"32","author":"Hirshberg","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0460","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1572-0241.2007.01477.x","article-title":"Prognostic factors in noncirrhotic patients with splanchnic vein thromboses","volume":"102","author":"Amitrano","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.thromres.2010.09.019_bb0465","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810005499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810005499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T04:37:05Z","timestamp":1592023025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384810005499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0049384810005499"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2010.09.019","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}